DGTHF yields 287.77% · PFE yields 6.13%● Live data
📍 DGTHF pulled ahead of the other in Year 1
Combined, DGTHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DGTHF + PFE for your $10,000?
DGTL Holdings Inc. incubates digital media and advertising technology companies using artificial intelligence in Canada and internationally. The company accelerates commercialized enterprise level software as-a-service companies through capitalization structures, including investment, mergers and acquisitions, earnouts, and licensing structures. It also offers Hashoff, a software-as-a-service platform provides micro-influencer marketing for brands; and TotalSocial, a platform-as-a-service focuses on the entire social ecosystem by combining powerful on-line and off-line data with predictive analytics. In addition, the company provides social intelligence using proprietary data and methodology for various brands and companies. The company was formerly known as Conscience Capital Inc. and changed its name to DGTL Holdings Inc. in July 2020. DGTL Holdings Inc. was incorporated in 2018 and is headquartered in Toronto, Canada.
Full DGTHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.